Report Detail
Global and Japan Biosimilar Insulin Market Insights, Forecast to 2026
- RnM4176362 |
- 31 August, 2020 |
- Global |
- 148 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilar Insulin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Biosimilar Insulin market is segmented into
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins
Segment by Application, the Biosimilar Insulin market is segmented into
Hospital
Clinic
Medical Center
Regional and Country-level Analysis
The Biosimilar Insulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilar Insulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilar Insulin Market Share Analysis
Biosimilar Insulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilar Insulin business, the date to enter into the Biosimilar Insulin market, Biosimilar Insulin product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Biogenomics
Eli Lilly
Gan&Lee Pharmaceuticals
Geropharm
Julphar Gulf Pharmaceutical Industries
Paras Biopharmaceuticals
Samsung Bioepis
Sedico
Wockhardt
Teva Pharmaceuticals
1 Study Coverage
- 1.1 Biosimilar Insulin Product Introduction
- 1.2 Market Segments
- 1.3 Key Biosimilar Insulin Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biosimilar Insulin Market Size Growth Rate by Type
- 1.4.2 Rapid Acting Insulins
- 1.4.3 Short Acting Insulins
- 1.4.4 Intermediate Insulins
- 1.4.5 Long Lasting Insulins
- 1.5 Market by Application
- 1.5.1 Global Biosimilar Insulin Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Medical Center
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biosimilar Insulin Market Size, Estimates and Forecasts
- 2.1.1 Global Biosimilar Insulin Revenue 2015-2026
- 2.1.2 Global Biosimilar Insulin Sales 2015-2026
- 2.2 Global Biosimilar Insulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Biosimilar Insulin Historical Market Size by Region (2015-2020)
- 2.3.1 Global Biosimilar Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Biosimilar Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Biosimilar Insulin Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Biosimilar Insulin Sales Forecast by Region (2021-2026)
- 2.4.2 Global Biosimilar Insulin Revenue Forecast by Region (2021-2026)
3 Global Biosimilar Insulin Competitor Landscape by Players
- 3.1 Global Top Biosimilar Insulin Sales by Manufacturers
- 3.1.1 Global Biosimilar Insulin Sales by Manufacturers (2015-2020)
- 3.1.2 Global Biosimilar Insulin Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Biosimilar Insulin Manufacturers by Revenue
- 3.2.1 Global Biosimilar Insulin Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Biosimilar Insulin Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biosimilar Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biosimilar Insulin Revenue in 2019
- 3.2.5 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Biosimilar Insulin Price by Manufacturers
- 3.4 Global Biosimilar Insulin Manufacturing Base Distribution, Product Types
- 3.4.1 Biosimilar Insulin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biosimilar Insulin Product Type
- 3.4.3 Date of International Manufacturers Enter into Biosimilar Insulin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Biosimilar Insulin Market Size by Type (2015-2020)
- 4.1.1 Global Biosimilar Insulin Sales by Type (2015-2020)
- 4.1.2 Global Biosimilar Insulin Revenue by Type (2015-2020)
- 4.1.3 Biosimilar Insulin Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biosimilar Insulin Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biosimilar Insulin Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biosimilar Insulin Revenue Forecast by Type (2021-2026)
- 4.2.3 Biosimilar Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biosimilar Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Biosimilar Insulin Market Size by Application (2015-2020)
- 5.1.1 Global Biosimilar Insulin Sales by Application (2015-2020)
- 5.1.2 Global Biosimilar Insulin Revenue by Application (2015-2020)
- 5.1.3 Biosimilar Insulin Price by Application (2015-2020)
- 5.2 Biosimilar Insulin Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biosimilar Insulin Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biosimilar Insulin Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biosimilar Insulin Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Biosimilar Insulin Market Size YoY Growth 2015-2026
- 6.1.1 Japan Biosimilar Insulin Sales YoY Growth 2015-2026
- 6.1.2 Japan Biosimilar Insulin Revenue YoY Growth 2015-2026
- 6.1.3 Japan Biosimilar Insulin Market Share in Global Market 2015-2026
- 6.2 Japan Biosimilar Insulin Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Biosimilar Insulin Players by Sales (2015-2020)
- 6.2.2 Japan Top Biosimilar Insulin Players by Revenue (2015-2020)
- 6.3 Japan Biosimilar Insulin Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Biosimilar Insulin Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Biosimilar Insulin Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Biosimilar Insulin Price by Type (2015-2020)
- 6.4 Japan Biosimilar Insulin Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Biosimilar Insulin Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Biosimilar Insulin Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Biosimilar Insulin Price Forecast by Type (2021-2026)
- 6.5 Japan Biosimilar Insulin Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Biosimilar Insulin Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Biosimilar Insulin Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Biosimilar Insulin Price by Application (2015-2020)
- 6.6 Japan Biosimilar Insulin Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Biosimilar Insulin Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Biosimilar Insulin Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Biosimilar Insulin Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Biosimilar Insulin Market Size YoY Growth 2015-2026
- 7.2 North America Biosimilar Insulin Market Facts & Figures by Country
- 7.2.1 North America Biosimilar Insulin Sales by Country (2015-2020)
- 7.2.2 North America Biosimilar Insulin Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Biosimilar Insulin Market Size YoY Growth 2015-2026
- 8.2 Europe Biosimilar Insulin Market Facts & Figures by Country
- 8.2.1 Europe Biosimilar Insulin Sales by Country
- 8.2.2 Europe Biosimilar Insulin Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Biosimilar Insulin Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Biosimilar Insulin Market Facts & Figures by Country
- 9.2.1 Asia Pacific Biosimilar Insulin Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Biosimilar Insulin Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Biosimilar Insulin Market Size YoY Growth 2015-2026
- 10.2 Latin America Biosimilar Insulin Market Facts & Figures by Country
- 10.2.1 Latin America Biosimilar Insulin Sales by Country
- 10.2.2 Latin America Biosimilar Insulin Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Biosimilar Insulin Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Biosimilar Insulin Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Biosimilar Insulin Sales by Country
- 11.2.2 Middle East and Africa Biosimilar Insulin Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Corporation Information
- 12.1.2 Pfizer Description and Business Overview
- 12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Pfizer Biosimilar Insulin Products Offered
- 12.1.5 Pfizer Recent Development
- 12.2 Biogenomics
- 12.2.1 Biogenomics Corporation Information
- 12.2.2 Biogenomics Description and Business Overview
- 12.2.3 Biogenomics Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Biogenomics Biosimilar Insulin Products Offered
- 12.2.5 Biogenomics Recent Development
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Corporation Information
- 12.3.2 Eli Lilly Description and Business Overview
- 12.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Eli Lilly Biosimilar Insulin Products Offered
- 12.3.5 Eli Lilly Recent Development
- 12.4 Gan&Lee Pharmaceuticals
- 12.4.1 Gan&Lee Pharmaceuticals Corporation Information
- 12.4.2 Gan&Lee Pharmaceuticals Description and Business Overview
- 12.4.3 Gan&Lee Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Gan&Lee Pharmaceuticals Biosimilar Insulin Products Offered
- 12.4.5 Gan&Lee Pharmaceuticals Recent Development
- 12.5 Geropharm
- 12.5.1 Geropharm Corporation Information
- 12.5.2 Geropharm Description and Business Overview
- 12.5.3 Geropharm Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Geropharm Biosimilar Insulin Products Offered
- 12.5.5 Geropharm Recent Development
- 12.6 Julphar Gulf Pharmaceutical Industries
- 12.6.1 Julphar Gulf Pharmaceutical Industries Corporation Information
- 12.6.2 Julphar Gulf Pharmaceutical Industries Description and Business Overview
- 12.6.3 Julphar Gulf Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Products Offered
- 12.6.5 Julphar Gulf Pharmaceutical Industries Recent Development
- 12.7 Paras Biopharmaceuticals
- 12.7.1 Paras Biopharmaceuticals Corporation Information
- 12.7.2 Paras Biopharmaceuticals Description and Business Overview
- 12.7.3 Paras Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Paras Biopharmaceuticals Biosimilar Insulin Products Offered
- 12.7.5 Paras Biopharmaceuticals Recent Development
- 12.8 Samsung Bioepis
- 12.8.1 Samsung Bioepis Corporation Information
- 12.8.2 Samsung Bioepis Description and Business Overview
- 12.8.3 Samsung Bioepis Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Samsung Bioepis Biosimilar Insulin Products Offered
- 12.8.5 Samsung Bioepis Recent Development
- 12.9 Sedico
- 12.9.1 Sedico Corporation Information
- 12.9.2 Sedico Description and Business Overview
- 12.9.3 Sedico Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Sedico Biosimilar Insulin Products Offered
- 12.9.5 Sedico Recent Development
- 12.10 Wockhardt
- 12.10.1 Wockhardt Corporation Information
- 12.10.2 Wockhardt Description and Business Overview
- 12.10.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Wockhardt Biosimilar Insulin Products Offered
- 12.10.5 Wockhardt Recent Development
- 12.11 Pfizer
- 12.11.1 Pfizer Corporation Information
- 12.11.2 Pfizer Description and Business Overview
- 12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Pfizer Biosimilar Insulin Products Offered
- 12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Biosimilar Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biosimilar Insulin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biosimilar Insulin. Industry analysis & Market Report on Biosimilar Insulin is a syndicated market report, published as Global and Japan Biosimilar Insulin Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Biosimilar Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
